Binding Characteristics of Anticancer Drug Doxorubicin with Two-Dimensional Graphene and Graphene Oxide: Insights from Density Functional Theory Calculations and Fluorescence Spectroscopy
Authors:
- 17 August 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry C
- Vol. 122 (36) , 21031-21038
Abstract
No abstract availableKeywords
Funding Information
- Vetenskapsr?det (2016-05366, 2016-06264, 2017-05447, 2014-4423)
- Knut och Alice Wallenbergs Stiftelse (KAW 2017.0055)
This publication has 48 references indexed in Scilit:
- Recent Advances in the Synthesis of Graphene-Based Nanomaterials for Controlled Drug DeliveryApplied Sciences, 2017
- Structural Characterization of Biofunctionalized Gold Nanoparticles by Ultrahigh-Resolution Mass SpectrometryACS Nano, 2017
- Building membrane nanoporesNature Nanotechnology, 2017
- Cancer: Nanoscience and Nanotechnology ApproachesACS Nano, 2017
- Facilitating the Clinical Integration of Nanomedicines: The Roles of Theoretical and Computational ScientistsACS Nano, 2016
- Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrierBiomaterials, 2014
- Injectable nanomaterials for drug delivery: Carriers, targeting moieties, and therapeuticsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- Functional Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer DrugsSmall, 2010
- Impact of Nanotechnology on Drug DeliveryACS Nano, 2009
- PEGylated Nanographene Oxide for Delivery of Water-Insoluble Cancer DrugsJournal of the American Chemical Society, 2008